AG8.F Agilent Technologies Inc

Healthcare Biotechnology Frankfurt Exchange
160.00 EUR
Close of Nov 11, 2026
93.85 164.60
Market cap
EUR 45.1B
P/E
37.0x
P/B
6.85x
ROE
18.2%
Dividend yield
0.57%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.

Is AG8.F undervalued?

Graham number

The Graham number of Agilent Technologies Inc cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Agilent Technologies Inc fundamental analysis

No fundamental analysis for Agilent Technologies Inc yet.

Agilent Technologies Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract dev…

Full company profile